Steve Powers: Okay. That makes sense. Is there any — I mean I guess the — is there any validity to the thought that because there was less spending in the first quarter, it exacerbated some of the weaker demand trends and [indiscernible].
Sean Connolly: No, I actually would say the opposite. We did see in one of our categories, a competitor try to do some promotional things to kind of force the issue and force and it didn’t work, and it didn’t have any impact on our business. And I can’t imagine what their bottom line looks like with such an inefficient spend. But it’s just — that’s what I mean by you have to be sometimes be smart, ride the wave in a patient a pragmatic way. If you get impatient and you try to do something irrational and force the consumer to do something they’re not ready to do, you know what you’re going to do, you’re going to spend a lot of money without having a lot of impact. And so we want to put our dollars and our investment out there in the marketplace on the right levers at the right time when the consumer is going to be responsive to it. And that’s why we’ve got the cadence of our spend laid out the way we’ve got across the full year.
Steve Powers: Understood. Okay. That’s very helpful. Thank you.
Operator: And our next question comes from Alexia Howard with Bernstein. Please go ahead.
Alexia Howard: Good morning, everyone.
Sean Connolly: Good morning.
Alexia Howard: So it seems as though the industry this year has been caught fairly flat footed with the surprising lack of recovery in volumes as price growth has slowed. Now it’s obviously still way too early to tell where the impact of the GLP-1 drugs is going to go, what the uptake is going to be over the next five, 10, 15 years. But in a similar vein, how can you start thinking about different scenarios for how that could play out, which parts of your portfolio might be most affected either positively or negatively? And how do you start getting data to decide which of those parts you might want to pursue? I mean, how do you plan for another potentially big consumer behavior shift that might be coming down the pipe over the next few years?
Sean Connolly: Alexia, I view that one a little bit differently. If you think about it, we’ve got an entire department of demand scientists here who are every day studying changes in consumer behavior, particularly — a particularly important one for our company has been the ever-evolving consumer definition of what constitutes healthy and how they want to eat in order to be responsive to health. Back in the ’90s with Snack Wells, it was all about fat and calories. And if you just look in the last few years, we’ve gone from grain-free to cauliflower to keto. I mean it’s constantly evolving. So what our demand science folks do is they’re constantly studying the trends that consumers are chasing, figuring out which of those need to be designed into our products and then adapting our products through our innovation program relentlessly so that we’re staying up with consumer trends.
So if we end up seeing changes in consumer eating patterns, let’s say they go to smaller portions, then we evolve the innovations, and we design smaller portions. If they switch to different types of nutrients, we evolve the innovation, we switch to different types of nutrients. If they change the kind of pack sizes they snack on, we’ll change that. So this is the kind of stuff that will happen over five, 10, 15 years, not over the next six months. But I think the key to navigating these kinds of just constantly evolving consumer environment is you have to be externally focused, you’ve got to study these consumer trends and you’ve got to rapidly design in what the consumer is looking for into your products and that’s what we do every year.
